Moore, Nicholas http://orcid.org/0000-0003-1212-2817
Duret, Stéphanie
Grolleau, Adeline
Lassalle, Régis
Barbet, Vanessa
Duong, Mai
Thurin, Nicolas
Droz-Perroteau, Cécile
Gulmez, Sinem Ezgi
Funding for this research was provided by:
IRESP (2013-29)
Article History
First Online: 25 October 2018
Compliance with Ethical Standards
:
: Nicholas Moore, Stéphanie Duret, Adeline Grolleau, Régis Lassalle, Vanessa Barbet, Mai Duong, Nicolas Thurin, Cécile Droz-Perroteau, and Sinem Ezgi Gulmez have no conflicts of interest that are directly relevant to the content of this study. All authors have completed the Unified Competing Interest form at ExternalRef removed (available on request from the corresponding author) and declare no support from any organisation for the submitted work and no other relationships or activities that could appear to have influenced the submitted work. Bordeaux PharmacoEpi receives funding from various pharmaceutical companies and governmental bodies to conduct research on marketed drugs at the request of regulatory authorities or as a consequence of research grant applications. None of these concern the subject at hand.
: This study was supported by an unconditional public joint grant from <i>Direction Générale de la Santé</i> (DGS), from <i>Mission recherche de la Direction de la recherche, des etudes, de l’évaluation et des statistiques</i> (MiRe-DREES) of <i>Caisse Nationale d’Assurance Maladie des Travailleurs Salariés</i> (CNAMTS), <i>Régime Social Indépendants</i> (RSI) and <i>Caisse Nationale de Solidarité́ pour l’Autonomie</i> (CNSA), as part of the general call for projects by IReSP (<i>Appel à Projets, Institut de Recherche en Santé Publique</i>), no. 2013-29. It was designed, conducted and analysed independently by the Bordeaux PharmacoEpi Research Platform, CIC Bordeaux CIC1401.
: In accordance with the French regulations, this study received authorisation from the Institute of Health Data (<i>Institut des Données de Santé</i>) and from the French Data Protection Commission (<i>Commission Nationale de l’Informatique et des Libertés</i>). This study was registered with ENCePP (ExternalRef removed), at the European Medicines Agency (EMA, London, UK), with the registration number ENCEPP/SDPP/7549.
: Not applicable.